Searching for a long-acting injectable formulation for the antiretroviral dolutegravir
The aim of this study was to engineer a DTG particle size able to provide plasma drug concentration maintenance above PA-IC-90 and, based on such drug prolonged- exposure, to evaluate the 30 days-acting injectable DTG feasibility for anti-HIV therapy. Liquid antisolvent precipitation technology was...
Saved in:
Main Authors: | , , , , , , |
---|---|
格式: | 圖書 |
出版: |
University of Huddersfield Press,
2019-12-01T00:00:00Z.
|
主題: | |
在線閱讀: | Connect to this object online. |
標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|
因特網
Connect to this object online.3rd Floor Main Library
索引號: |
A1234.567 |
---|---|
復印件 1 | 可用 |